Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03889418 · ClinicalTrials.gov registry record · NA

Opioid Treatment and Recovery Through a Safe Pain Management Program

A NA study, sponsored by Ochsner Health System.

Completed
Registry status
NA
Development phase
490
Enrollment target

NCT03889418: Completed NA study, sponsored by Ochsner Health System.

NCT03889418 is a NA study that has completed, run by Ochsner Health System. The registered enrollment target is 490 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03889418, a NA study, has completed, sponsored by Ochsner Health System.

COMPLETED
Registry status
NA
Development phase
490 participants
Enrollment target

Study Summary

Opioid prescription drug abuse has become a major public health concern in the United States with mortality rates from fatal overdoses reaching epidemic proportions. This opioid crisis coincides with national efforts to improve management of chronic non-cancer pain. The net result, however, has been ever-growing increases in medical expenditures related to prescription costs and increased healthcare service utilization among opioid abusers. Healthcare provider prescribing pattern, especially among non-pain management specialists such as primary care, is a major factor. Louisiana is a major contributor to the epidemic with the 7th highest opioid prescribing rates accompanied by a 12% increase in fatal overdoses. Providers are overdue for implementing safe opioid management strategies in primary care to combat the opioid crisis. Recent practice guidelines provide recommendations on what to do for safe prescribing of opioids, but they do not provide guidance on how to translate them into practice. Health systems must find ways to accelerate guideline adoption in primary care in the face of an overdose crisis. Research that examines a combination workflow- and provider-focused strategies are needed. Given the high prevalence of psychiatric disorders among patients with chronic non-cancer pain, care team expansion with integration of collaborative mental/behavioral health services may be the solution. Collaborative care can extend opioid management beyond standardized monitoring of risk factors for opioid misuse or abuse and set clear protocols for next steps in management. This study is aligned with the National Institute on Drug Abuse's interest in health systems research that examines approaches to screening, assessment, prevention, diagnosis and treatment for prescription drug abuse. It will examine the primary care practice redesign of managing chronic non-cancer pain within a large health system whose 40+ Accountable Care Network-affiliated, adult primary care cl

Primary Outcome

Participants' opioid medication orders were monitored for 12 months prior to and following entry into study (index event). This outcome represents the odds of having an average MEDD ≥ 50 mg in the pre-index and post-index periods for the collaborative care and usual care groups. Odds of an event is defined as the ratio of the probability that the event will happen (prescribed high dose opioid) to the probability that the event will not happen (not prescribed high dose opioid)

Interventions

  • BEHAVIORAL Electronic medical recorded clinical decision support [EMR CDS]
  • BEHAVIORAL Stepped opioid collaborative care model [CCM]

Trial Details

FieldValue
Enrollment Target 490 participants
Start Date 2019-04-01
Est. Completion 2023-06-30
Phase NA
Ochsner Health System

29 total trials

What the finished NCT03889418 record still lists

NCT03889418 is an interventional study that assigns participants to a tested intervention. The registered 490 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).

The record links to 0 conditions, and to 2 interventions - of which Electronic medical recorded clinical decision support [EMR CDS] is the first listed.

NCT03889418 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03889418 about?

NCT03889418 is a clinical study titled "Opioid Treatment and Recovery Through a Safe Pain Management Program". Opioid prescription drug abuse has become a major public health concern in the United States with mortality rates from fatal overdoses reaching epidemic proportions. This opioid crisis coincides with national efforts to improve management of chronic non-cancer pain. The net result, however, has been...

What is the current status of trial NCT03889418?

This trial is currently completed. It is a NA study. The enrollment target is 490 participants. The study started on 2019-04-01. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT03889418?

The interventions under investigation include: Electronic medical recorded clinical decision support [EMR CDS] (BEHAVIORAL), Stepped opioid collaborative care model [CCM] (BEHAVIORAL).

Who is sponsoring clinical trial NCT03889418?

This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03889418's enrollment target sits among peer trials

490 215th of 2000 higher than 1,786 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04728893 · 490 participants · Phase 2

    Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • NCT06238479 · 490 participants · Phase 1

    A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

  • NCT06336928 · 490 participants

    A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

  • NCT06641414 · 490 participants · Phase 3

    Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03889418, the US trial registry maintained by the National Library of Medicine. NCT03889418 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.